Cellectis’ Annual Shareholders’ General Meeting to be Held on June 28, 2022

Published on May 23, 2022 in New York, NY

Back to all press releases

NEW YORK, May 23, 2022 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its combined general meeting on June 28, 2022 at 2:30 p.m. CET at the Company's offices at 8 rue de la Croix Jarry (4th floor) 75013 Paris, France.

The notice announcing the General Meeting details the agenda and modalities of participation for the meeting, and will be made available on the Company’s website: https://cellectis.com/en/investors/general-meetings/

Download the PDF file